Skip to main content

ADVERTISEMENT

retrograde PCI

Original Contribution
11/15/2017

Peter Tajti, MD1,2,3;  Aris Karatasakis, MD3;  Dimitri Karmpaliotis, MD4;  Khaldoon Alaswad, MD5;  Farouc A. Jaffer, MD, PhD6;  Robert W. Yeh, MD7;  Mitul Patel, MD8;  Ehtisham Mahmud, MD8;  James W. Choi, MD9; Anthony H. Doing, MD10;  Catalin Toma, MD11;  Barry Uretsky, MD12;  Santiago Garcia, MD13;  Jeffrey W. Moses, MD4;  Manish Parikh, MD4;  Ajay Kirtane, MD4;  Ziad A. Ali, MD4;  Raja Hatem, MD4;  Judit Karacsonyi, MD2,3;  Barbara A. Danek, MD3;  Bavana V. Rangan, BDS, MPH3;  Subhash Banerjee, MD3;  Imre Ungi, MD, PhD2;  Emmanouil S. Brilakis, MD, PhD1,3

Peter Tajti, MD1,2,3;  Aris Karatasak...
We compared the clinical and procedural characteristics and outcomes of retrograde CTO-PCI through LIMA grafts vs other conduits in a contemporary multicenter CTO registry.
We compared the clinical and procedural characteristics and outcomes of retrograde CTO-PCI through LIMA grafts vs other conduits in a contemporary multicenter CTO registry.
We compared the clinical and...
11/15/2017
Journal of Invasive Cardiology